SciSparc to Acquire Xylo’s MUSE Endoscopy IP Portfolio

Reuters
2025/11/26
SciSparc to Acquire Xylo's MUSE Endoscopy IP Portfolio

SciSparc Ltd. has signed a binding term sheet to acquire a portfolio of patents, trademarks, and intellectual property rights related to innovative endoscopic systems and medical cameras, including the MUSE™ system, from Xylo Technologies Ltd. The MUSE™ system is a single-use, minimally invasive endoscopic device for treating gastroesophageal reflux disease (GERD) via transoral fundoplication. As consideration for the acquired assets, SciSparc will issue new ordinary shares representing 19.99% of its issued and outstanding share capital to Xylo, with the option to issue pre-funded warrants instead. Building on previous commercialization efforts in Greater China, SciSparc plans to expand the MUSE™ system's reach into additional global markets through exclusive regional partnerships.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9592784-en) on November 26, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10